Fibrinogen gamma-chain dodecapeptide

CAS : 89105-94-2

Ref. 3D-FF73382

Informations sur le produit

• Nom: Fibrinogen gamma-chain dodecapeptide
• Synonymes: L-Valine,N-[N-[N-[N-[N2-[N2-[N-[N-[N-[N-(N-L-histidyl-L-histidyl)-L-leucyl]glycyl]glycyl]-L-alanyl]-L-lysyl]-L-glutaminyl]-L-alanyl]glycyl]-L-a-aspartyl]-, Fibrinogen g-chain fragment analog, Fibrinogen-binding inhibitor peptide, Human fibrinogen g-400-411 peptide, 10: PN: JP2002320666SEQID: 10 claimed protein, 125: PN: WO2008058016 SEQID: 126 claimed protein, 1: PN: US7049140 SEQID: 1 claimed protein, 29: PN: WO0155210 SEQID: 29 unclaimedsequence, 4: PN: WO2004058305 PAGE: 39 claimed protein, 6: PN: WO0066182 SEQID: 1 claimedprotein, His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val
• CAS: 89105-94-2

Description

Fibrinogen gamma-chain dodecapeptide (FgGDP) is a synthetic drug that binds to the thrombin receptor and blocks the binding of thrombin to fibrinogen. FgGDP inhibits platelet aggregation by preventing the formation of prothrombinase complexes on the surface of erythrocytes. This drug has been shown to be effective in treating patients with unstable angina and acute myocardial infarction, as well as those undergoing percutaneous coronary intervention. FgGDP is also used in research to study blood clots and their dissolution. FgGDP is not labeled for use in humans as it is an unlabeled biologic drug.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,189.28 g/mol
• Formule: C₅₀H₈₀N₁₈O₁₆
• Degré de pureté: Min. 95%